NCT01872221View on ClinicalTrials.gov

Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Glioblastoma
Interventions
PROCEDURE

Surgery (based on preoperative multimodal MRI) followed by the standard radio-chemotherapy stupp protocol

Trial Locations (2)

31000

CHU Rangueil, Toulouse

31052

Institut Claudius REGAUD, Toulouse

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT01872221 - Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study | Biotech Hunter | Biotech Hunter